Uzhachenko Roman, Ivanov Sergey V, Yarbrough Wendell G, Shanker Anil, Medzhitov Ruslan, Ivanova Alla V
1 Department of Biochemistry and Cancer Biology, VICC, Meharry Medical College , Nashville, Tennessee.
Antioxid Redox Signal. 2014 Apr 1;20(10):1533-47. doi: 10.1089/ars.2013.5437. Epub 2014 Feb 4.
Fus1 has been established as mitochondrial tumor suppressor, immunomodulator, and antioxidant protein, but molecular mechanism of these activities remained to be identified. Based on putative calcium-binding and myristoyl-binding domains that we identified in Fus1, we explored our hypothesis that Fus1 regulates mitochondrial calcium handling and calcium-coupled processes.
Fus1 loss resulted in reduced rate of mitochondrial calcium uptake in calcium-loaded epithelial cells, splenocytes, and activated CD4(+) T cells. The reduced rate of mitochondrial calcium uptake in Fus1-deficient cells correlated with cytosolic calcium increase and dysregulation of calcium-coupled mitochondrial parameters, such as reactive oxygen species production, ΔμH(+), mitochondrial permeability transition pore opening, and GSH content. Inhibition of calcium efflux via mitochondria, Na(+)/Ca(2+) exchanger significantly improved the mitochondrial calcium uptake in Fus1(-/-) cells. Ex vivo analysis of activated CD4(+) T cells showed Fus1-dependent changes in calcium-regulated processes, such as surface expression of CD4 and PD1/PD-L1, proliferation, and Th polarization. Fus1(-/-) T cells showed increased basal expression of calcium-dependent NF-κB and NFAT targets but were unable to fully activate these pathways after stimulation.
Our results establish Fus1 as one of the few identified regulators of mitochondrial calcium handling. Our data support the idea that alterations in mitochondrial calcium dynamics could lead to the disruption of metabolic coupling in mitochondria that, in turn, may result in multiple cellular and systemic abnormalities.
Our findings suggest that Fus1 achieves its protective role in inflammation, autoimmunity, and cancer via the regulation of mitochondrial calcium and calcium-coupled parameters.
Fus1已被确认为一种线粒体肿瘤抑制因子、免疫调节因子和抗氧化蛋白,但其这些活性的分子机制仍有待确定。基于我们在Fus1中鉴定出的假定钙结合和肉豆蔻酰结合结构域,我们探讨了Fus1调节线粒体钙处理和钙偶联过程的假说。
Fus1缺失导致钙负载的上皮细胞、脾细胞和活化的CD4(+) T细胞中线粒体钙摄取速率降低。Fus1缺陷细胞中线粒体钙摄取速率降低与胞质钙增加以及钙偶联线粒体参数失调相关,如活性氧生成、ΔμH(+)、线粒体通透性转换孔开放和谷胱甘肽含量。通过线粒体钠/钙交换体抑制钙外流可显著改善Fus1(-/-)细胞中的线粒体钙摄取。对活化的CD4(+) T细胞的体外分析表明,Fus1依赖性改变了钙调节过程,如CD4和PD1/PD-L1的表面表达、增殖和Th极化。Fus1(-/-) T细胞显示钙依赖性NF-κB和NFAT靶标的基础表达增加,但在刺激后无法完全激活这些途径。
我们的结果确定Fus1是少数已确定的线粒体钙处理调节因子之一。我们的数据支持这样一种观点,即线粒体钙动力学的改变可能导致线粒体中代谢偶联的破坏,进而可能导致多种细胞和全身异常。
我们的研究结果表明,Fus1通过调节线粒体钙和钙偶联参数在炎症、自身免疫和癌症中发挥其保护作用。